The Immune System – Products

Cytokines are central to understanding autoimmune diseases and advancing treatments. Targeted therapies improve patient outcomes and quality of life. To support drug development, we have designed recombinant cytokines and receptor proteins.

This whitepaper discusses the classification of bsAbs targeting immunomodulatory checkpoints and highlights their applications in cancer immunotherapy.

Lonza’s XS Technologies® platform, with Pichia and E. coli, enables scalable protein production for 130+ projects, including enzymes and biologics. Flexible tools optimize yield and quality, accelerating therapy development. License XS® for your lab!

Thermo Fisher Scientific has introduced the Invitrogen Vivofectamine™ Delivery Solutions to provide high-performance lipid nanoparticles (LNP) technology for non-viral delivery of nucleic acids.

This application focus explores how IMC can be applied to identify major cell populations that make up mouse brain matter.

Oxford Nanopore, announced a landmark strategic partnership with the UK Government. This partnership brings together the UK’s world-class scientific organisations Genomics England, UK Biobank and NHS England, alongside Oxford Nanopore.

Transgene and ProBioGen, announce that the companies have entered into a license agreement for ProBioGen’s AGE1.CR.pIX® suspension cell line.

The life science group Sartorius has published its second edition High-Throughput Screening (HTS) by Cytometry handbook.

eXmoor pharma, and Virica Biotech Inc. (“Virica”), announced a new project funded in part through a joint Canada-UK government biomanufacturing collaboration.

Click the picture to learning more about using pre-fusion glycoprotein F for evaluating vaccine efficacy against RSV